top of page


Biologics CMC Series (4): Biologics Control Strategy—Integrating Process, Analytics, and Regulatory Requirements
Biologics quality cannot rely on release testing alone. This guide explains how to build an integrated strategy across materials, manufacturing, analytics, specifications, and continued monitoring.

Jason Lu
Aug 3011 min read


Biologics CMC Series (3): ICH Q5E Comparability After Manufacturing Changes
Passing release specifications does not establish comparability. Learn how ICH Q5E integrates risk assessment, analytical characterization, stability, process data, and regulatory strategy.

Jason Lu
Aug 2214 min read
bottom of page
